Literature DB >> 20843900

Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.

Monica Beneyto1, Andrew Abbott, Takanori Hashimoto, David A Lewis.   

Abstract

Dysfunction of the dorsolateral prefrontal cortex (DLPFC) in schizophrenia is associated with lamina-specific alterations in particular subpopulations of interneurons. In pyramidal cells, postsynaptic γ-aminobutyric acid (GABA(A)) receptors containing different α subunits are inserted preferentially in distinct subcellular locations targeted by inputs from specific interneuron subpopulations. We used in situ hybridization to quantify the laminar expression of α1, α2, α3, and α5 subunit, and of β1-3 subunit, mRNAs in the DLFPC of schizophrenia, and matched normal comparison subjects. In subjects with schizophrenia, mean GABA(A) α1 mRNA expression was 17% lower in layers 3 and 4, α2 expression was 14% higher in layer 2, α5 expression was 15% lower in layer 4, and α3 expression did not differ relative to comparison subjects. The mRNA expression of β2, which preferentially assembles with α1 subunits, was also 20% lower in layers 3 and 4, whereas β1 and β3 mRNA levels were not altered in schizophrenia. These expression differences were not attributable to medication effects or other potential confounds. These findings suggest that GABA neurotransmission in the DLPFC is altered at the postsynaptic level in a receptor subunit- and layer-specific manner in subjects with schizophrenia and support the hypothesis that GABA neurotransmission in this illness is predominantly impaired in certain cortical microcircuits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843900      PMCID: PMC3077427          DOI: 10.1093/cercor/bhq169

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  71 in total

1.  GABAergic depolarization of the axon initial segment in cortical principal neurons is caused by the Na-K-2Cl cotransporter NKCC1.

Authors:  Stanislav Khirug; Junko Yamada; Ramil Afzalov; Juha Voipio; Leonard Khiroug; Kai Kaila
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

Review 2.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

3.  Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.

Authors:  Harvey M Morris; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2008-01-17       Impact factor: 5.357

4.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

5.  Synaptic alpha 5 subunit-containing GABAA receptors mediate IPSPs elicited by dendrite-preferring cells in rat neocortex.

Authors:  Afia B Ali; Alex M Thomson
Journal:  Cereb Cortex       Date:  2007-10-19       Impact factor: 5.357

6.  Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia.

Authors:  David A Lewis; Raymond Y Cho; Cameron S Carter; Kevin Eklund; Sarah Forster; Mary Ann Kelly; Debra Montrose
Journal:  Am J Psychiatry       Date:  2008-10-15       Impact factor: 18.112

Review 7.  GABA A receptors: subtypes provide diversity of function and pharmacology.

Authors:  Richard W Olsen; Werner Sieghart
Journal:  Neuropharmacology       Date:  2008-08-08       Impact factor: 5.250

8.  Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.

Authors:  Monica Beneyto; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2007-11-21       Impact factor: 7.853

9.  Selective, state-dependent activation of somatostatin-expressing inhibitory interneurons in mouse neocortex.

Authors:  Erika E Fanselow; Kristen A Richardson; Barry W Connors
Journal:  J Neurophysiol       Date:  2008-09-17       Impact factor: 2.714

10.  Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.

Authors:  Stephen M Eggan; Takanori Hashimoto; David A Lewis
Journal:  Arch Gen Psychiatry       Date:  2008-07
View more
  62 in total

1.  Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases.

Authors:  C E Adams; J C Yonchek; K M Schulz; S L Graw; J Stitzel; P U Teschke; K E Stevens
Journal:  Neuroscience       Date:  2012-01-25       Impact factor: 3.590

2.  Elevated viral restriction factor levels in cortical blood vessels in schizophrenia.

Authors:  Benjamin I Siegel; Elizabeth J Sengupta; Jessica R Edelson; David A Lewis; David W Volk
Journal:  Biol Psychiatry       Date:  2013-09-30       Impact factor: 13.382

3.  Effects of chronic inhibition of GABA synthesis on attention and impulse control.

Authors:  Tracie A Paine; Elizabeth K Cooke; Daniel C Lowes
Journal:  Pharmacol Biochem Behav       Date:  2015-06-01       Impact factor: 3.533

4.  Selective pyramidal cell reduction of GABA(A) receptor α1 subunit messenger RNA expression in schizophrenia.

Authors:  Jill R Glausier; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2011-06-15       Impact factor: 7.853

Review 5.  GABA abnormalities in schizophrenia: a methodological review of in vivo studies.

Authors:  Stephan F Taylor; Ivy F Tso
Journal:  Schizophr Res       Date:  2014-10-25       Impact factor: 4.939

Review 6.  Using human brain imaging studies as a guide toward animal models of schizophrenia.

Authors:  S S Bolkan; F Carvalho Poyraz; C Kellendonk
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 7.  GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Res       Date:  2014-11-26       Impact factor: 4.939

8.  Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome.

Authors:  Juliet Richetto; Francesca Calabrese; Marco A Riva; Urs Meyer
Journal:  Schizophr Bull       Date:  2013-01-17       Impact factor: 9.306

9.  Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.

Authors:  J R Glausier; K N Fish; D A Lewis
Journal:  Mol Psychiatry       Date:  2013-11-12       Impact factor: 15.992

10.  Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1.

Authors:  Dong-Min Yin; Yong-Jun Chen; Yi-Sheng Lu; Jonathan C Bean; Anupama Sathyamurthy; Chengyong Shen; Xihui Liu; Thiri W Lin; Clifford A Smith; Wen-Cheng Xiong; Lin Mei
Journal:  Neuron       Date:  2013-05-22       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.